Los Angeles, CA10 Active Studies

Sleep Apnea Clinical Trials in Los Angeles, CA

Find 10 actively recruiting sleep apnea clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
2,790
Enrolling

Recruiting Sleep Apnea Studies in Los Angeles

RecruitingLos Angeles, CANCT05691478

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

This phase II/III trial tests the safety, side effects, and best dose of the drug cabozantinib in combination with standard chemotherapy, and to compare the effect of adding cabozantinib to standard c...

1,122 participants
National Cancer Institute (NCI)
View Study Details
RecruitingLos Angeles, CANCT06088290

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

The primary objective of this phase III study is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma (LMS) prolongs the pr...

450 participants
PharmaMar
View Study Details
RecruitingLos Angeles, CANCT05712694

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline....

300 participants
Polaris Group
View Study Details
RecruitingLos Angeles, CANCT06043440

Down Syndrome Obstructive Sleep Apnea

The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) w...

230 participants
Brigham and Women's Hospital
View Study Details
RecruitingLos Angeles, CANCT05304585

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) whi...

205 participants
Children's Oncology Group
View Study Details
RecruitingLos Angeles, CANCT06388200

A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mut...

150 participants
Ocugen
View Study Details
RecruitingLos Angeles, CANCT06127407

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Study CL3-95031-007 (CHONQUER) is a Phase 3, international, multicenter, double-blind, randomized, placebo-controlled study of orally administered ivosidenib. Participants are required to have a histo...

136 participants
Servier Bio-Innovation LLC
View Study Details
RecruitingLos Angeles, CANCT05111574

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

This phase II trial tests whether nivolumab in combination with cabozantinib works in patients with mucosal melanoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's i...

99 participants
National Cancer Institute (NCI)
View Study Details
RecruitingLos Angeles, CANCT06341712

Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma

The participants of this study will be children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery. Participants will have achieved a partia...

90 participants
Ipsen
View Study Details
RecruitingLos Angeles, CANCT04173650

MSC EVs in Dystrophic Epidermolysis Bullosa

INVESTIGATIONAL PRODUCT: AGLE-102 is an allogeneic extracellular vesicle (EV) product derived from normal donor mesenchymal stem cells (MSCs). INDICATION AND RATIONALE: The aim of the study is to ass...

8 participants
Aegle Therapeutics
View Study Details

About Sleep Apnea Clinical Trials in Los Angeles

Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts during sleep. Obstructive sleep apnea (OSA) is the most common form. Treatment includes CPAP therapy, oral appliances, lifestyle changes, and in some cases surgery.

There are currently 10 sleep apnea clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 2,790 participants. Research is being sponsored by National Cancer Institute (NCI), PharmaMar, Polaris Group and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sleep Apnea Clinical Trials in Los Angeles — FAQ

Are there sleep apnea clinical trials in Los Angeles?

Yes, there are 10 sleep apnea clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What sleep apnea treatments are being tested?

The 10 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for sleep apnea.

Data updated March 2, 2026 from ClinicalTrials.gov